New Key Statistics Module, Z-Score and F-Score
XSWX:GSK Key Ratios
Market Cap CHF M | 66,480.76 |
Enterprise Value CHF M | 81,238.71 |
P/E(ttm) | 17.61 |
PE Ratio without NRI | 15.92 |
Forward PE Ratio | 11.52 |
Price/Book | 5.25 |
Price/Sales | 2.50 |
Price/Free Cash Flow | 14.27 |
Price/Owner Earnings | 13.00 |
Payout Ratio % | 0.38 |
Revenue (TTM) CHF M | 33,407.00 |
EPS (TTM) CHF | 0.41 |
Beneish M-Score | -2.69 |
10-y EBITDA Growth Rate % | 1.10 |
5-y EBITDA Growth Rate % | 1.00 |
y-y EBITDA Growth Rate % | -6.50 |
EV-to-EBIT | 13.94 |
EV-to-EBITDA | 10.28 |
PEG | 15.92 |
Shares Outstanding M | 4,094.93 |
Net Margin (%) | 14.59 |
Operating Margin % | 21.97 |
Pre-tax Margin (%) | 17.93 |
Quick Ratio | 0.58 |
Current Ratio | 0.87 |
ROA % (ttm) | 7.56 |
ROE % (ttm) | 34.58 |
ROIC % (ttm) | 12.07 |
Dividend Yield % | 3.20 |
Altman Z-Score | 1.97 |
XSWX:GSK Number of Guru Trades
XSWX:GSK Volume of Guru Trades
Gurus Latest Trades with XSWX:GSK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XSWX:GSK is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data